Large trial tests effectiveness of common diabetes meds
Glargine and liraglutide were more effective in achieving target HbA1c levels than glimepiride and sitagliptin when added to metformin, US researchers say
Two common diabetes medications seem to outperform two others when it comes to controlling BSLs , a large US trial has found.
The trial of more than 5000 people with type 2 diabetes found that two injection medications — a long-acting insulin and liraglutide (Victoza) — typically worked better than two oral drugs in keeping BSLs in check.
Over five years, patients taking either injection treatment spent more time with their blood glucose in the recommended range — an average of six extra months.
Still, most study patients were unable to meet that goal for the long haul. Experts said it underscored how difficult that task was for people with diabetes.
